Waqas Ali, DO
Interventional Pain Medicine · Rockwall, TXNPI 1942861638
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $11,596 with a category attached, or 86.2%. Medtronic accounts for 87.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $10,373 and has fallen 98.8% since, to $121 in 2025.
Across 35 payments — averaging $331.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Nevro Corp.$456
- Abbott$278
- Inari Medical, Inc.$272
- Boston Scientific$186
- MML US, Inc.$132
- plus $178 from 7 others
What the payments were for
- Grants$10,00086%
- Travel & lodging$130%
- Food & beverage$1,58314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $10,094 |
| Nevro Corp. | 4 | $456 |
| Abbott | 6 | $278 |
| Inari Medical, Inc. | 4 | $272 |
| Boston Scientific | 5 | $186 |
| MML US, Inc. | 2 | $132 |
| Bioventus LLC | 2 | $47 |
| Painteq LLC | 2 | $39 |
| Averitas Pharma Inc. | 1 | $27 |
| Globus Medical | 1 | $18 |
| Spinal Simplicity, LLC | 1 | $16 |
| Curonix LLC | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$10,000
- Senza$379
- FLOWTRIEVER CATHETER, S$193
- CT THROMBECTOMY SYSTEM KIT$193
- ETERNA$142
- ReActiv8$116
How this compares
$11,596 in reported general payments places this provider in the 65th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 121 | $3,110 |
| Lidocaine | 16 | $1,551 |
| Pregabalin | 59 | $1,152 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $1,101 |
| Diclofenac Sodium | 30 | $780 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $719 |
| Duloxetine Hcl | 41 | $558 |
| Baclofen | 22 | $475 |
| Gabapentin | 42 | $452 |
| Tramadol Hcl | 29 | $414 |
| Methadone Hcl | 20 | $411 |
| Meloxicam | 101 | $283 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $271 |
| Methocarbamol | 19 | $110 |
| Tizanidine Hcl | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Rockwall
- Tibor RaczRockwall$22K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.